Ludwig researchers describe how acidity turns oxygen-starved cancer cells dormant and drug resistant—and a potentially easy way reverse the effect.
A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which cells enter a state of dormancy as tissues starved of oxygen become increasingly acidic. The study, led by Chi Van Dang, scientific director of the Ludwig Institute for Cancer Research, has potentially significant implications for cancer therapy: Large swaths of solid tumors are often deprived of oxygen, and cells in such patches are thought to be a major source of drug resistance and disease relapses.
Published today in the journal Cell, the study details how in response to acidity cells turn off a critical molecular switch known as mTORC1 that, in ordinary conditions, gauges the availability of nutrients before giving cells the green light to grow and divide. That event, Dang and his colleagues show, shuts down the cell’s production of proteins, disrupting their metabolic activity and circadian clocks, and pushing them into a quiescent state. They also demonstrate that this acid-mediated effect might be relatively easy to reverse—a finding that could help improve a variety of cancer therapies.
“In tumors grafted into mice, we see mTOR activity in spotty places where there’s oxygen,” says Dang who is also a professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute. “But if you add baking soda to the drinking water given to those mice, the entire tumor lights up with mTOR activity. The prediction would be that by reawakening these cells, you could make the tumor far more sensitive to therapy.”
Baking soda had previously been reported to enhance cancer immunotherapy by one of the co-authors of the new study, Robert Gillies of the H. Lee Moffitt Cancer Center, though the mechanism underlying the effect was unclear.
Dang’s team, including co-corresponding author Zandra Walton, an MD-PhD student at the University of Pennsylvania Perelman School of Medicine, discovered that mechanism through an intricate series of experiments done at the University of Pennsylvania and Dang’s Ludwig lab at the Wistar Institute. It centers on the behavior of lysosomes—a sack-like cellular organelle that digests proteins and that mTOR moves to when it is ready for action.
The researchers show that in acidic conditions protein motors propel lysosomes carrying mTOR away from the area around the nucleus, where they’re ordinarily located. This separates mTOR from a protein required for its activation, RHEB, which continues to hang around at that location. Lacking one of its key activation signals, mTOR remains dormant, suspending the synthesis of proteins—including the components of the cell’s molecular clock—along with most metabolic activity.
“Cells don’t want to make proteins or other biomolecules when they’re under stress,” says Dang. “They want to slow things down and only awaken when things return to normal.”
The researchers show that baking soda can reverse this effect. When given to mice in their drinking water, it surprisingly sufficed to neutralize the acidity of hypoxic patches in tumors. This sent lysosomes zipping back to the nuclear periphery in cells—where RHEB was waiting—and restored the activity of mTOR.
All this is relevant to cancer because researchers have long known that quiescent cells cannot typically be killed by chemotherapy. Notably, Dang and his team also found that T cell activation, which is essential to most immunotherapies, is similarly compromised under acidic conditions.
“We started out with a question about oxygen starvation and the circadian clock, and we ended up discovering a new mechanism by which acidic conditions in tissues shut off a lot of things—including the cell’s molecular clock,” muses Dang.
The finding that something as simple as baking soda could possibly help reverse this effect and render quiescent cancer cells susceptible to cancer therapies excites Dang.
“The concept is so easy,” he says. “It’s not some $100,000 per year drug. It’s literally just baking soda.” Dang and his team are now looking into how acidity might affect immunotherapy and further exploring the acid-induced quiescence of cancer cells.
Learn more: HOW MIGHT BAKING SODA BOOST CANCER THERAPY?
The Latest on: Cancer therapy
via Google News
The Latest on: Cancer therapy
- Anal cancer rises by up to 111% in the UK - these are the symptoms to look out foron November 30, 2019 at 11:31 am
And it’s not just the UK, scientists from The University of Texas in Houston found anal cancer rose by up to 2.7% every year between 2001 and 2015 in the US. One sufferer was Desperate Housewives’ ...
- Cancer survivors report an information gap in treatment side effectson November 30, 2019 at 12:08 am
Share on Pinterest A new patient survey reveals the information needs of people receiving cancer treatment. About one-third of people in the U.S. will develop cancer, according to the American Cancer ...
- Japan Approves Genetic Testing For Breast Cancer Treatmenton November 29, 2019 at 8:12 am
This month, Japan’s Ministry of Health, Labour and Welfare approved the BRACAnalysis® Diagnostic System, also known as the “BRACAnalysis” genetic test, to be used to test which breast cancer patients ...
- Health Canada approves Kadcyla® (trastuzumab emtansine) for the treatment of HER2-positive early breast cancer after surgery(1)on November 28, 2019 at 4:21 pm
5 Early breast cancer, defined as the presence of a tumour which is confined solely to the breast and has not spread beyond the axillary lymph nodes or to other organs, 6,7 typically involves a ...
- A Small Number Of Men With Prostate Cancer Are ‘Super Responders’ To Immunotherapyon November 28, 2019 at 4:03 pm
Results from a new clinical trial have shown that some men with advanced prostate cancer can live for at least two more years on immunotherapy after exhausting all other treatment options. The work ...
- Current use of stereotactic body radiation therapy for low and intermediate risk prostate cancer: A National Cancer Database Analysison November 28, 2019 at 6:48 am
Recent studies have demonstrated both safety and efficacy of stereotactic body radiation therapy (SBRT) as monotherapy in the treatment of low and intermediate risk prostate cancer. Our study aims to ...
- Microfluidic cancer treatment screen combined with flow cytometryon November 28, 2019 at 3:28 am
Radiotherapy (RT) and chemotherapy (CT) are two major cancer treatment strategies but can fail for certain cancer types. However, combination therapy could provide a useful advancement, challenging ...
- Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastaseson November 28, 2019 at 2:18 am
Bevacizumab is FDA-approved in the treatment of primary brain tumors, but its efficacy in patients with brain metastases could be better-studied. This study examines a population of non-small cell ...
- Bone Cancer Treatment Market Growth, Size, Opportunity & Industry Analysis, 2018-2026on November 27, 2019 at 9:26 pm
The bone cancer treatment market is analyzed on the basis of type of bone cancer into primary bone cancer and secondary bone cancer. Primary bone cancer originates from fast and uncontrollable growth ...
via Bing News